ConductScience.org, home

Paper798024

Further investigations on the mode of entry of vaccinia virus into cells.

Chang A and 1 other. J Gen Virol, 1976. Cited by 113 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Further investigations on the mode of entry of vaccinia virus into cells. Papers, record 798024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/798024

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Further investigations on the mode of entry of vaccinia virus into cells.
PubMed
Journal
J Gen Virol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
113
iCite
Relative citation ratio, by iCite
2.54
iCite
Revised in PubMed
2019-12-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chang AA
2Metz DHD H

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Vaccinia virusMajor topic
Adsorption
Antigens, Viral
Cell Membrane
Ferritins
HeLa Cells
Immunologic Techniques
L Cells

Source PubMed

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.

PMIDTitleJournalYearIn PapersSource
42,405,773Structure and functional analyses of vaccinia virus J5 protein reveal distinct determinants for entry-fusion complex assembly and activation.J Virol2026https://conductscience.org/library/papers/42405773PubMed
38,148,355Mpox (formerly monkeypox): pathogenesis, prevention, and treatment.Signal Transduct Target Ther2023https://conductscience.org/library/papers/38148355PubMed
37,948,471Structural and functional analysis of vaccinia viral fusion complex component protein A28 through NMR and molecular dynamic simulations.PLoS Pathog2023https://conductscience.org/library/papers/37948471PubMed
35,967,174Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment.Cureus2022https://conductscience.org/library/papers/35967174PubMed
31,220,181Vaccinia viral A26 protein is a fusion suppressor of mature virus and triggers membrane fusion through conformational change at low pH.PLoS Pathog2019https://conductscience.org/library/papers/31220181PubMed
28,659,486Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein.J Virol2017https://conductscience.org/library/papers/28659486PubMed
26,041,286Intracellular Transport of Vaccinia Virus in HeLa Cells Requires WASH-VPEF/FAM21-Retromer Complexes and Recycling Molecules Rab11 and Rab22.J Virol2015https://conductscience.org/library/papers/26041286PubMed
22,359,015Effect of serum type and concentration on the expression ofβ-galactosidase in recombinant vaccinia virus infected HeLa S3 cells.Cytotechnology1995https://conductscience.org/library/papers/22359015PubMed
22,345,471The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis.J Virol2012https://conductscience.org/library/papers/22345471PubMed
22,278,246Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH.J Virol2012https://conductscience.org/library/papers/22278246PubMed
21,994,664Lipid membranes in poxvirus replication.Viruses2010https://conductscience.org/library/papers/21994664PubMed
20,538,855Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells.J Virol2010https://conductscience.org/library/papers/20538855PubMed
20,526,370Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis.PLoS One2010https://conductscience.org/library/papers/20526370PubMed
19,428,041Vaccinia virus strain differences in cell attachment and entry.Virology2009https://conductscience.org/library/papers/19428041PubMed
19,395,056Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.Virology2009https://conductscience.org/library/papers/19395056PubMed
19,369,327Disulfide bond formation at the C termini of vaccinia virus A26 and A27 proteins does not require viral redox enzymes and suppresses glycosaminoglycan-mediated cell fusion.J Virol2009https://conductscience.org/library/papers/19369327PubMed
19,264,647Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.J Gen Virol2009https://conductscience.org/library/papers/19264647PubMed
19,162,290Vaccinia virus exhibits cell-type-dependent entry characteristics.Virology2009https://conductscience.org/library/papers/19162290PubMed
19,036,815Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.J Virol2009https://conductscience.org/library/papers/19036815PubMed
18,550,675A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.J Virol2008https://conductscience.org/library/papers/18550675PubMed

See all 53 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/798024

GET https://conductscience.org/api/papers/v1/798024/cited_by?page=2